openPR Logo
Press release

Netupitant–Palonosetron Market Expected to Reach $527,187 Million, by 2022

02-07-2017 11:32 AM CET | Health & Medicine

Press release from: Allied Industry Research

According to a new report published by Allied Market Research, titled, “Netupitant Palonosetron Market: Global Opportunity Analysis and Industry Forecast, 2014–2022”, the global netupitant–palonosetron was valued at $257,162 million in 2015, and is expected to reach $527,187 million by 2022, growing at a CAGR of 10.8% from 2016 to 2022.

Summary of the Netupitant-Palonosetron Market Report can be accessed on the website at: https://www.alliedmarketresearch.com/netupitant-palonosetron-FDC-market

Netupitant–palonosetron FDC market holds a substantial scope for growth globally. The market is in its growth stage; however, its contribution to the global market is expected to increase significantly within the next six years. High cost is a major limitation to for the growth of the market in developing regions. However, recent innovations, which embed high potential and longer duration of action within the CINV drugs reach a wider segment of audiences. Numerous players are stepping in the CINV market with innovative products. Emerging technology such as novel drugs discovery and innovation of antiemetic therapy are expected to increase the competition in the near future.

KEY FINDINGS OF THE STUDY
• North America dominated the netupitant–palonosetron market, and is expected to grow at a CAGR of 9.9%.
• Asia-Pacific shows the highest growth rate, and is estimated to grow at a CAGR of 14.7%.
Key players profiled in this report include Acacia Pharma, Helsinn Holding S.A., Heron Therapeutics, Inc., and Eisai Pharmaceutical Pvt Ltd.
Summary of Similar Reports can be accessed at: https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Netupitant–Palonosetron Market Expected to Reach $527,187 Million, by 2022 here

News-ID: 430480 • Views:

More Releases from Allied Industry Research

Footwear Market is Expected to Reach $371.8 Billion, Globally, by 2020
Footwear Market is Expected to Reach $371.8 Billion, Globally, by 2020
Footwear Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $371.8 billion by 2020, registering a CAGR of 5.5% during the period 2015 - 2020.The Asia Pacific region is a major exporter of leather footwear to the United States and United Kingdom and ranks as the highest revenue generating region in the footwear market worldwide. Summary of the report: https://www.alliedmarketresearch.com/footwear-market The region generated
Global Forklift Truck Market Expected to Reach $51 Billion by 2022
According to a new report published by Allied Market Research, titled, “Forklift Truck Market by Product Type, Engine Power, End User, and Class: Global Opportunity Analysis and Industry Forecast, 2014–2022,” the global forklift truck market is estimated to reach $51 billion by 2022, growing at a CAGR of 6.6% during the forecast period. Asia-Pacific accounted for the highest market share in 2015, and is anticipated to maintain its dominance throughout
Water Treatment Technology Market Expected to Reach $192,715 Million by 2022
According to a new report published by Allied Market Research, titled, “Water Treatment Technology Market by Pumping Systems, Chemicals, and Membrane Systems: Global Opportunity Analysis and Industry Forecast, 2014–2022,” the water treatment technology market was valued at $145,082 million in 2015 and is projected to reach $192,715 million by 2022, growing at a CAGR of 4.1% from 2016 to 2022. Valves & controls segment dominated this market, occupying more than

All 4 Releases


More Releases for Netupitant

Navigating the Global Netupitant-Palonosetron FDC Market: Trends, Impacts, and F …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: As the healthcare landscape continues to evolve, pharmaceutical innovations play a crucial role in improving patient outcomes and enhancing treatment experiences. One such advancement is the development of fixed-dose combinations (FDCs) like Netupitant-Palonosetron. This blog delves into the dynamics of the global Netupitant-Palonosetron FDC market, analyzing its size, share, and the impact of COVID-19, while also forecasting trends up to 2031. 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐍𝐞𝐭𝐮𝐩𝐢𝐭𝐚𝐧𝐭-𝐏𝐚𝐥𝐨𝐧𝐨𝐬𝐞𝐭𝐫𝐨𝐧 𝐅𝐃𝐂: Netupitant-Palonosetron FDC is a combination therapy used primarily
Netupitant - Palonosetron Market Expected to Reach $527,187 Million, Globally, b …
Netupitant Palonosetron Market Report was valued at $257,162 million in 2015, and is expected to reach $527,187 million by 2022, growing at a CAGR of 10.8% from 2016 to 2022. 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Acacia Pharma, Helsinn Holding S.A., Heron Therapeutics, Inc., and Eisai Pharmaceutical Pvt Ltd. are some of the major players discussed in the report 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1831 Netupitantpalonosetron FDC market holds a substantial scope for growth globally. The
Netupitant - Palonosetron Market Outlook, Size, Share and Growth Stance Forecast …
Netupitantpalonosetron FDC market holds a substantial scope for growth globally. The market is in its growth stage; however, its contribution to the global market is expected to increase significantly within the next six years. 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Acacia Pharma, Helsinn Holding S.A., Heron Therapeutics, Inc., and Eisai Pharmaceutical Pvt Ltd. are some of the major players discussed in the report. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1831 𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘 North America dominated
Netupitant-Palonosetron FDC Market In Depth Analysis 2021 To 2071Eisai Pharmaceu …
 The research study presented here is an intelligent take on the global Netupitant-Palonosetron FDC Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of the report that reflect its authenticity. The authors of the report have focused on SWOT analysis, Porter’s Five Forces analysis, and PESTLE analysis of the global Netupitant-Palonosetron FDC market. In addition,
Netupitant-Palonosetron FDC Market Industry Analysis, Trend and Growth, 2017-202 …
Netupitant-Palonosetron is the first approved fixed dose combination drug for the prevention of chemotherapy induced nausea and vomiting. Cancer is a leading cause of death worldwide, accounting nearly 1.4 million new cases in 2012. The most common type of cancer is lung cancer accounting about 1.59 million deaths, globally. Other prominent cancers are liver cancer, breast cancer, stomach cancer, esophageal and stomach cancer. In 2012, nearly 8.2 million deaths occurred
Netupitant-Palonosetron FDC Market - Global Opportunity Analysis and Industry Fo …
Preimplantation genetic diagnosis (PGD) also referred as embryo screening, is a branch of genetics involves in genetic testing of embryo through in-vitro fertilization (IVF). PGD eliminates risk of selective pregnancy termination for couples who are at substantial risk of transferring serious genetic, chromosomal, or hereditary disorders such as spinal muscular atrophy and cystic fibrosis. Ask for a sample Copy of report @ https://goo.gl/7cWV1h The global PGD market size is estimated to be